| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
| geminin | 13 | 0 | 0 | 13 |
| lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Protein-tyrosine-phosphatase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 7 | 0 | 9 |
| Carbonic anhydrase 2 | 0 | 7 | 0 | 9 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 3 |
| Tyrosine-protein phosphatase non-receptor type 5 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 4 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| TDP1 protein | 10 | 0 | 0 | 10 |
| AR protein | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| estrogen receptor 2 (ER beta) | 7 | 0 | 0 | 7 |
| progesterone receptor | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 10 | 0 | 0 | 10 |
| estrogen-related nuclear receptor alpha | 9 | 0 | 0 | 9 |
| estrogen nuclear receptor alpha | 15 | 0 | 0 | 15 |
| IDH1 | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 8 | 0 | 0 | 8 |
| Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 8 | 0 | 0 | 8 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 11 | 0 | 0 | 11 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| ATP-binding cassette sub-family C member 3 | 0 | 8 | 0 | 8 |
| Multidrug resistance-associated protein 4 | 0 | 8 | 0 | 9 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
| Bile salt export pump | 0 | 11 | 0 | 11 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| Cellular tumor antigen p53 | 9 | 0 | 0 | 9 |
| Glutamate receptor 2 | 4 | 0 | 0 | 4 |
| Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 0 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 4 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
| Canalicular multispecific organic anion transporter 1 | 0 | 8 | 0 | 8 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 4 | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| GLS protein | 1 | 0 | 0 | 1 |
| farnesoid X nuclear receptor | 9 | 0 | 0 | 9 |
| peroxisome proliferator-activated receptor delta | 7 | 0 | 0 | 7 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
| peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
| Cytochrome P450 1A2 | 0 | 3 | 0 | 3 |
| Cytochrome P450 3A4 | 0 | 7 | 1 | 9 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2C9 | 0 | 6 | 0 | 6 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 6 |
| Aurora kinase B | 0 | 3 | 0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 0 | 4 |
| Chain A, Avidin | 0 | 0 | 1 | 1 |
| Chain A, Protein (streptavidin) | 0 | 0 | 1 | 1 |
| Chain B, Protein (streptavidin) | 0 | 0 | 1 | 1 |
| Chain A, Streptavidin | 0 | 0 | 1 | 1 |
| Chain D, Streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Streptavidin | 0 | 0 | 1 | 1 |
| Chain D, Streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Streptavidin | 0 | 0 | 1 | 1 |
| Chain D, Streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Streptavidin Complex With Biotin | 0 | 0 | 1 | 1 |
| Chain D, Circularly Permuted Core-streptavidin E51/a46 | 0 | 0 | 1 | 1 |
| Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Avidin | 0 | 0 | 1 | 1 |
| Chain A, Streptavidin | 0 | 0 | 1 | 1 |
| Chain B, Streptavidin | 0 | 0 | 1 | 1 |
| Chain A, Streptavidin | 0 | 0 | 1 | 1 |
| Chain B, Streptavidin | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 8 | 0 | 0 | 8 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| nonstructural protein 1 | 0 | 1 | 0 | 1 |
| green fluorescent protein, partial | 0 | 1 | 0 | 1 |
| insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| USP1 protein, partial | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | 8 | 0 | 0 | 8 |
| retinoid X nuclear receptor alpha | 10 | 0 | 0 | 10 |
| pregnane X nuclear receptor | 9 | 0 | 0 | 9 |
| G | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| Interferon beta | 8 | 0 | 0 | 8 |
| HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
| Carbonic anhydrase 4 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| SMAD family member 2 | 4 | 0 | 0 | 4 |
| SMAD family member 3 | 4 | 0 | 0 | 4 |
| GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 2 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Chain A, STEROID DELTA-ISOMERASE | 0 | 0 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| Steroid Delta-isomerase | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Ileal sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Bile acid receptor | 0 | 0 | 1 | 1 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 5 | 0 | 0 | 5 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
| Prostacyclin receptor | 0 | 2 | 1 | 3 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
| Ornithine transcarbamylase, mitochondrial | 0 | 1 | 0 | 1 |
| Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| acetylcholinesterase | 1 | 0 | 0 | 1 |
| unnamed protein product | 0 | 1 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 0 | 0 | 3 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Chymotrypsinogen A | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 4 | 0 | 4 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 2 | 3 |
| Aromatase | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 0 | 0 | 3 |
| Cytochrome P450 11B1, mitochondrial | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 0 | 0 | 3 |
| Cytochrome P450 11B2, mitochondrial | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 0 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 0 | 0 | 3 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 0 | 0 | 3 |
| Malate dehydrogenase, cytoplasmic | 0 | 2 | 0 | 2 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 0 | 0 | 3 |
| Cytochrome P450 144 | 0 | 0 | 2 | 2 |
| Steroid C26-monooxygenase | 0 | 0 | 2 | 2 |
| Steroid C26-monooxygenase | 0 | 0 | 2 | 2 |
| Mycocyclosin synthase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 5 | 2 | 7 |
| Sterol 14-alpha demethylase | 0 | 0 | 2 | 2 |
| Sterol 14-alpha demethylase | 0 | 2 | 2 | 4 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 3 | 0 | 0 | 3 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 0 | 0 | 3 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
| EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Albumin | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| Luciferase | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| WRN | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| CDK5 | 0 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 1 | 0 | 0 | 1 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 3 | 0 | 0 | 3 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| large T antigen | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| GALC protein | 1 | 0 | 0 | 1 |
| polyprotein | 2 | 0 | 0 | 2 |
| Estrogen receptor beta | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Platelet-activating factor receptor | 0 | 1 | 0 | 1 |
| M-phase inducer phosphatase 1 | 0 | 1 | 0 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
| Chain H, Igg2b-kappa 40-50 Fab (heavy Chain) | 0 | 1 | 0 | 1 |
| Chain L, Igg2b-kappa 40-50 Fab (light Chain) | 0 | 1 | 0 | 1 |
| Chain A, Na, K-ATPase alpha subunit | 0 | 0 | 1 | 1 |
| ATAD5 protein, partial | 1 | 0 | 0 | 1 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| Kruppel-like factor 5 | 0 | 1 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
| Ataxin-2 | 2 | 0 | 0 | 2 |
| Protein arginine N-methyltransferase 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Protein tyrosine phosphatase type IVA 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Coagulation factor X | 0 | 1 | 0 | 1 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Protein S100-B | 0 | 1 | 1 | 2 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Protein S100-B | 0 | 0 | 1 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Acrosin | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Amiloride-sensitive amine oxidase [copper-containing] | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Diamine acetyltransferase 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Protein tyrosine phosphatase type IVA 2 | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| 10 kDa chaperonin | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Protein tyrosine phosphatase type IVA 1 | 0 | 1 | 0 | 1 |
| Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
| Sterol 14-alpha-demethylase | 0 | 0 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Chain A, Prostatic Acid Phosphatase | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 0 | 1 | 1 |
| Protein kinase C gamma type | 0 | 1 | 1 | 2 |
| Protein kinase C beta type | 0 | 1 | 1 | 2 |
| Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
| Protein kinase C alpha type | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 0 | 1 | 1 |
| Protein kinase C iota type | 0 | 0 | 1 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 0 | 1 | 1 |
| Protein kinase C zeta type | 0 | 0 | 1 | 1 |
| Protein kinase C delta type | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 1 |
| Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| Cadherin-1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Adenomatous polyposis coli protein | 0 | 1 | 0 | 1 |
| Catenin beta-1 | 0 | 2 | 0 | 2 |
| Tyrosine-protein kinase SYK | 0 | 1 | 0 | 1 |
| Transcription factor 7-like 2 | 0 | 1 | 0 | 1 |
| Receptor-type tyrosine-protein phosphatase F | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 6 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 11 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |